Contact Us
Global Point Of Care Infectious Disease Testing Market Report 2025

Point Of Care Infectious Disease Testing Global Market Report 2025 - By Product (Kits And Reagents, Instruments), By Technology (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies), By Disease (Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases), By End Use (Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Point Of Care Infectious Disease Testing Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Point Of Care Infectious Disease Testing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Point Of Care Infectious Disease Testing Market?

Point of care (POC) infectious disease testing refers to diagnostic tests that are performed at or near the site of patient care, such as hospitals, clinics, doctors’ offices, or even at home. These tests are designed to detect infectious diseases quickly and accurately, providing immediate results to facilitate prompt treatment decisions. POC tests are typically user-friendly, require minimal equipment, and offer results within minutes to hours, making them ideal for situations where timely diagnosis is crucial.

The main product types in point of care infectious disease testing are kits and reagents, and instruments. Kits and reagents are pre-prepared components used in point-of-care diagnostics to quickly detect infectious agents through reactions with patient samples. Technologies used include lateral flow immunoassay, agglutination tests, flow-through tests or immunoconcentration assays, and molecular diagnostics, among others, while the diseases tested for include human immunodeficiency virus (HIV), clostridium difficile, hepatitis B virus, pneumonia or streptococcus-associated infections, respiratory syncytial virus, human papillomavirus, influenza, and others. Point-of-care testing is used by various end-users, including hospitals, diagnostic centers, research and academic institutes, homecare settings, and others.

Point Of Care Infectious Disease Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Point Of Care Infectious Disease Testing Market Size 2025 And Growth Rate?

The point of care infectious disease testing market size has grown rapidly in recent years. It will grow from $4.21 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to increasing demand for quick diagnostic solutions, rising incidence of infectious diseases, rise in healthcare awareness, increasing healthcare expenditure, and rise in the adoption of home care and self-testing solutions.

What Is The Point Of Care Infectious Disease Testing Market Growth Forecast?

The point of care infectious disease testing market size is expected to see rapid growth in the next few years. It will grow to $8.02 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to rising demand for rapid diagnostics, increasing prevalence of infectious diseases, growing adoption in remote and resource-limited settings, shift toward decentralized healthcare, supportive government initiatives, and funding. Major trends in the forecast period include advancement in molecular diagnostics, advanced point of care testing devices, innovation in biosensors and detection technologies, advancement in mobile health applications, and innovative partnerships between healthcare providers and tech companies.

How Is The Point Of Care Infectious Disease Testing Market Segmented?

The point of care infectious disease testing market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies

3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases

4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users

Subsegments:

1) By Kits And Reagents: Test Kits, Reagents

2) By Instruments: Portable Devices, automated analyzers

What Is Driving The Point Of Care Infectious Disease Testing Market? The Rising Contagious Disease Is Fueling The Market Growth Due To The Increasing Need For Rapid Diagnosis And Containment

The rising contagious disease is expected to propel the growth of the point of care infectious disease testing market going forward. A contagious disease refers to an illness that can be spread from one person to another through direct contact, airborne droplets, or other means of transmission. The rising incidence of contagious diseases is primarily due to increasing human mobility, as greater movement of people across regions and countries facilitates faster and wider transmission of infectious agents. Point of care infectious disease testing accelerates the detection and diagnosis of contagious diseases, enabling timely treatment and reducing the risk of transmission within communities. For instance, in June 2024, according to the UK Health Security Agency, a UK-based government agency, between week 40 of 2022 and week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. In contrast, the previous flu season had only 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. Therefore, the rising contagious disease is driving the growth of point of care infectious disease testing market.

Who Are The Major Players In The Global Point Of Care Infectious Disease Testing Market?

Major companies operating in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc.

What Are The Key Trends Of The Global Point Of Care Infectious Disease Testing Market? The Role Of Proprietary Microfluidic Technology In Diagnostic Advancements

Major companies operating in the point-of-care infectious disease testing market are focusing on integrating innovative technologies such as proprietary microfluidic technology to enhance test accuracy, reduce time-to-results, and improve patient outcomes. Proprietary microfluidic technology refers to specialized systems that manipulate small volumes of fluids at the microscale, enabling rapid, precise, and cost-effective analysis, which helps point of care (POC) infectious disease testing by allowing on-site, fast pathogen detection with integrated sample collection, analysis, and result output, enhancing diagnostic speed and accessibility without the need for centralized laboratory testing. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA-100 AST System in Europe, marking the world’s first point-of-care testing solution for directly detecting antimicrobial susceptibility. Utilizing advanced microfluidic technology, the system enables rapid identification of bacterial infections and evaluation of antimicrobial effectiveness, significantly reducing processing time compared to conventional methods. It comprises a compact, desktop-sized analyzer and single-use sample cartridges, making it well-suited for near-patient settings such as primary care clinics. Designed to facilitate faster and more accurate antimicrobial therapy decisions, the system contributes to the global effort to combat antimicrobial resistance by improving diagnostic efficiency.

What Are Latest Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market? Roche Acquires Lumiradx's Point Of Care Technology To Enhance Diagnostic Access

In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired LumiraDx’s point of care technology for $295 million. With this acquisition, Roche aims to expand global access to decentralized diagnostic testing by integrating LumiraDx’s versatile point-of-care platform into its diagnostics portfolio, enabling timely and actionable results across primary care and underserved healthcare settings. LumiraDx is a US-based medical equipment manufacturing company that specializes in providing point of care infectious disease testing.

What Is The Regional Outlook For The Global Point Of Care Infectious Disease Testing Market?

North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point of care infectious disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Point Of Care Infectious Disease Testing Market?

The point-of-care infectious disease testing market consists of revenues earned by entities by providing services such as rapid diagnostic testing, disease screening, and onsite sample analysis for infectious conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care infectious disease testing market also includes sales of handheld analyzers, lateral flow assays, molecular testing devices, and related consumables used for the immediate detection of infectious diseases. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Point Of Care Infectious Disease Testing Industry?

The point of care infectious disease testing market research report is one of a series of new reports from The Business Research Company that provides point of care infectious disease testing market statistics, including the point of care infectious disease testing industry global market size, regional shares, competitors with the point of care infectious disease testing market share, detailed point of care infectious disease testing market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care infectious disease testing industry. This point of care infectious disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Point Of Care Infectious Disease Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.79 billion
Revenue Forecast In 2034 $8.02 billion
Growth Rate CAGR of 13.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The point of care infectious disease testing market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases
4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users Subsegments:
1) By Kits And Reagents: Test Kits, Reagents
2) By Instruments: Portable Devices, Automated Analyzers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Point Of Care Infectious Disease Testing Market Characteristics

    3. Point Of Care Infectious Disease Testing Market Trends And Strategies

    4. Point Of Care Infectious Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Point Of Care Infectious Disease Testing Growth Analysis And Strategic Analysis Framework

    5.1. Global Point Of Care Infectious Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Point Of Care Infectious Disease Testing Market Growth Rate Analysis

    5.4. Global Point Of Care Infectious Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Point Of Care Infectious Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Point Of Care Infectious Disease Testing Total Addressable Market (TAM)

    6. Point Of Care Infectious Disease Testing Market Segmentation

    6.1. Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Kits And Reagents

    Instruments

    6.2. Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lateral Flow Immunoassay

    Agglutination Test

    Flow-Through Test Or Immunoconcentration Assay

    Molecular Diagnostics

    Other Technologies

    6.3. Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Human Immunodeficiency Virus Point-Of-Care Testing

    Clostridium Difficile Point-Of-Care Testing

    Hepatitis B Virus Point-Of-Care Testing

    Pneumonia Or Streptococcus Associated Infections

    Respiratory Syncytial Virus Point-Of-Care Testing

    Human Papillomavirus Point-Of-Care Testing

    Influenza Or Flu Point-Of-Care Testing

    Other Diseases

    6.4. Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Centers

    Research And Academic Institutes

    Homecare Settings

    Other End Users

    6.5. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Test Kits

    Reagents

    6.6. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Portable Devices

    Automated Analyzers

    7. Point Of Care Infectious Disease Testing Market Regional And Country Analysis

    7.1. Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Point Of Care Infectious Disease Testing Market

    8.1. Asia-Pacific Point Of Care Infectious Disease Testing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Point Of Care Infectious Disease Testing Market

    9.1. China Point Of Care Infectious Disease Testing Market Overview

    9.2. China Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Point Of Care Infectious Disease Testing Market

    10.1. India Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Point Of Care Infectious Disease Testing Market

    11.1. Japan Point Of Care Infectious Disease Testing Market Overview

    11.2. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Point Of Care Infectious Disease Testing Market

    12.1. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Point Of Care Infectious Disease Testing Market

    13.1. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Point Of Care Infectious Disease Testing Market

    14.1. South Korea Point Of Care Infectious Disease Testing Market Overview

    14.2. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Point Of Care Infectious Disease Testing Market

    15.1. Western Europe Point Of Care Infectious Disease Testing Market Overview

    15.2. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Point Of Care Infectious Disease Testing Market

    16.1. UK Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Point Of Care Infectious Disease Testing Market

    17.1. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Point Of Care Infectious Disease Testing Market

    18.1. France Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Point Of Care Infectious Disease Testing Market

    19.1. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Point Of Care Infectious Disease Testing Market

    20.1. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Point Of Care Infectious Disease Testing Market

    21.1. Eastern Europe Point Of Care Infectious Disease Testing Market Overview

    21.2. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Point Of Care Infectious Disease Testing Market

    22.1. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Point Of Care Infectious Disease Testing Market

    23.1. North America Point Of Care Infectious Disease Testing Market Overview

    23.2. North America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Point Of Care Infectious Disease Testing Market

    24.1. USA Point Of Care Infectious Disease Testing Market Overview

    24.2. USA Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Point Of Care Infectious Disease Testing Market

    25.1. Canada Point Of Care Infectious Disease Testing Market Overview

    25.2. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Point Of Care Infectious Disease Testing Market

    26.1. South America Point Of Care Infectious Disease Testing Market Overview

    26.2. South America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Point Of Care Infectious Disease Testing Market

    27.1. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Point Of Care Infectious Disease Testing Market

    28.1. Middle East Point Of Care Infectious Disease Testing Market Overview

    28.2. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Point Of Care Infectious Disease Testing Market

    29.1. Africa Point Of Care Infectious Disease Testing Market Overview

    29.2. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Point Of Care Infectious Disease Testing Market Competitive Landscape And Company Profiles

    30.1. Point Of Care Infectious Disease Testing Market Competitive Landscape

    30.2. Point Of Care Infectious Disease Testing Market Company Profiles

    30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

    31. Point Of Care Infectious Disease Testing Market Other Major And Innovative Companies

    31.1. Becton Dickinson and Company

    31.2. Quest Diagnostics Incorporated

    31.3. bioMérieux Société Anonyme

    31.4. QuidelOrtho Corporation

    31.5. Bio-Rad Laboratories Inc.

    31.6. DiaSorin Società per Azioni

    31.7. Danaher Corporation

    31.8. Cue Health Inc.

    31.9. Nova Biomedical Corporation

    31.10. Seegene Incorporated

    31.11. Biosynex Société Anonyme

    31.12. Trivitron Healthcare Private Limited

    31.13. EKF Diagnostics Holdings plc

    31.14. Trinity Biotech Public Limited Company

    31.15. bioLytical Laboratories Inc.

    32. Global Point Of Care Infectious Disease Testing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market

    34. Recent Developments In The Point Of Care Infectious Disease Testing Market

    35. Point Of Care Infectious Disease Testing Market High Potential Countries, Segments and Strategies

    35.1 Point Of Care Infectious Disease Testing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Point Of Care Infectious Disease Testing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Point Of Care Infectious Disease Testing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Cardinal Health Financial Performance
  • Table 78: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Cardinal Health Financial Performance
  • Figure 78: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Siemens Healthineers AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Point Of Care Infectious Disease Testing market?

Point of care (POC) infectious disease testing refers to diagnostic tests that are performed at or near the site of patient care, such as hospitals, clinics, doctors’ offices, or even at home. These tests are designed to detect infectious diseases quickly and accurately, providing immediate results to facilitate prompt treatment decisions. POC tests are typically user-friendly, require minimal equipment, and offer results within minutes to hours, making them ideal for situations where timely diagnosis is crucial. For further insights on the Point Of Care Infectious Disease Testing market, request a sample here

How will the Point Of Care Infectious Disease Testing market drivers and restraints affect the market dynamics? What forces will shape the Point Of Care Infectious Disease Testing industry going forward?

The Point Of Care Infectious Disease Testing market major growth driver - The Rising Contagious Disease Is Fueling The Market Growth Due To The Increasing Need For Rapid Diagnosis And Containment. For further insights on the Point Of Care Infectious Disease Testing market, request a sample here

What is the forecast market size or the forecast market value of the Point Of Care Infectious Disease Testing market?

The Point Of Care Infectious Disease Testing market size has grown strongly in recent years. The point of care infectious disease testing market size has grown rapidly in recent years. It will grow from $4.21 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to increasing demand for quick diagnostic solutions, rising incidence of infectious diseases, rise in healthcare awareness, increasing healthcare expenditure, and rise in the adoption of home care and self-testing solutions. The point of care infectious disease testing market size is expected to see rapid growth in the next few years. It will grow to $8.02 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to rising demand for rapid diagnostics, increasing prevalence of infectious diseases, growing adoption in remote and resource-limited settings, shift toward decentralized healthcare, supportive government initiatives, and funding. Major trends in the forecast period include advancement in molecular diagnostics, advanced point of care testing devices, innovation in biosensors and detection technologies, advancement in mobile health applications, and innovative partnerships between healthcare providers and tech companies. For further insights on the Point Of Care Infectious Disease Testing market, request a sample here

How is the Point Of Care Infectious Disease Testing market segmented?

The point of care infectious disease testing market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases
4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users
Subsegments:
1) By Kits And Reagents: Test Kits, Reagents
2) By Instruments: Portable Devices, Automated Analyzers For further insights on the Point Of Care Infectious Disease Testing market,
request a sample here

Which region has the largest share of the Point Of Care Infectious Disease Testing market? What are the other regions covered in the report?

North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Point Of Care Infectious Disease Testing market, request a sample here.

Who are the major players in the Point Of Care Infectious Disease Testing market?

Major companies operating in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc. . For further insights on the Point Of Care Infectious Disease Testing market, request a sample here.

What are the key trends in the Point Of Care Infectious Disease Testing market?

Major trends in the Point Of Care Infectious Disease Testing market include The Role Of Proprietary Microfluidic Technology In Diagnostic Advancements. For further insights on the Point Of Care Infectious Disease Testing market, request a sample here.

What are the major opportunities in the Point Of Care Infectious Disease Testing market? What are the strategies for the Point Of Care Infectious Disease Testing market?

For detailed insights on the major opportunities and strategies in the Point Of Care Infectious Disease Testing market, request a sample here.

How does the Point Of Care Infectious Disease Testing market relate to the overall economy and other similar markets?

For detailed insights on Point Of Care Infectious Disease Testing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Point Of Care Infectious Disease Testing industry?

For detailed insights on the mergers and acquisitions in the Point Of Care Infectious Disease Testing industry, request a sample here.

What are the key dynamics influencing the Point Of Care Infectious Disease Testing market growth? SWOT analysis of the Point Of Care Infectious Disease Testing market.

For detailed insights on the key dynamics influencing the Point Of Care Infectious Disease Testing market growth and SWOT analysis of the Point Of Care Infectious Disease Testing industry, request a sample here.